ASH Clinical Practice Guidelines on Immune Thrombocytopenia
Over recent years, there has been an increase in available treatment options, evidence, and clinical experience related to the management of adults with primary immune thrombocytopenia (ITP). The 2026 ASH guidelines focus on initial and second-line therapy for adults with primary ITP and provide evidence-based recommendations to support treatment decision-making.
The 2019 ASH guidelines on ITP remain available on this page for recommendations on diagnosis, management, and other aspects of ITP care.
Guideline Implementation Tools and Resources
Visual Summary
This concise visual aid is intended to support understanding of the recommendations and to aid in clinical decision-making:
Teaching Slides
Educational slide sets to teach about ITP.
2026 slide set for initial and second-line therapy in adults with primary ITP
2019 slide set to help diagnose, manage, and treat ITP
Pocket Guides
The following pocket guides are based on the 2019 ASH Clinical Practice Guidelines for Immune Thrombocytopenia (ITP) and do not include recommendations from 2026:
Summary of 2026 Updates
Table describing key updates to the 2019 recommendations.
